Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) saw a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 7 shares, a decline of 99.9% from the July 15th total of 5,660 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 4,968 shares, the days-to-cover ratio is currently 0.0 days.

Medicure Stock Performance

Shares of Medicure stock opened at $0.85 on Wednesday. The company’s 50 day moving average price is $0.76 and its two-hundred day moving average price is $0.81. The firm has a market capitalization of $8.87 million, a P/E ratio of -1.81 and a beta of 0.99. Medicure has a fifty-two week low of $0.67 and a fifty-two week high of $0.97. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.04 and a quick ratio of 0.73.

Medicure (OTCMKTS:MCUJF) last announced its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01. The company had revenue of $5.79 million during the quarter, compared to analysts’ expectations of $3.63 million. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.